0000727346 false 0000727346 2023-03-06 2023-03-06 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): March 6, 2023

 

SELECTIS HEALTH, INC.

(Exact Name of Registrant as Specified in its Charter)

 

Utah   0-15415   87-0340206

(State or other jurisdiction

of incorporation)

 

Commission
File Number

 

(I.R.S. Employer
Identification number)

 

8480 E. Orchard Road, Ste. 4900, Greenwood Village, CO 80111

(Address of principal executive offices)         (Zip Code)

 

Registrant’s telephone number, including area code: (720) 680-0808

 

 

(Former name or former address, if changed since last report)

 

Written communications pursuant to Rule 425 under the Securities Act
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each Class   Trading Symbol   Name of each exchange on which registered
N/A   N/A   N/A

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 
 

 

ITEM 5.02DEPARTURE OF EXECUTIVE OFFICER AND DIRECTOR; APPOINTMENT OF EXECUTIVE OFFICER

 

On March 6, 2023, Christine Lucus tendered her resignation as Chief Financial Officer of Selectis Health, Inc. (the “Company”), effective April 5, 2023. Lance Baller, our current CEO, will serve as the Company’s principal financial officer until we identify a permanent CFO. The Company has engaged an outside accounting and consulting firm to assist the Company with customary and required accounting functions and financial reporting.

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

   

Selectis Health, Inc.

(Registrant)

     
  Dated: March 10, 2023 /s/ Lance Baller
    Lance Baller, CEO

 

 

Selectis Health (PK) (USOTC:GBCS)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Selectis Health (PK) Charts.
Selectis Health (PK) (USOTC:GBCS)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Selectis Health (PK) Charts.